Origin Sciences
PrivateLast Round
VC Round
Oct 21, 2014
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Origin Sciences operates in Healthcare & Life Sciences and is based in the United Kingdom. Its latest recorded funding round was a VC Round in October 2014.
Origin Sciences is a medical technology company that develops diagnostic devices and tests for the detection and monitoring of gastrointestinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Origin Sciences Comparables
Compare Origin Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Geneoscopy | 74% | |
| Cyted Health | 72% | |
| Guardant Health | 61% |
For institutional investors. Book with your work email.
Origin Sciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Origin Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CSVE Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 99% MoM.
- Aug 10, 2026
Open roles increased to 7, 3.5x the trailing average.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- invests_into_assetsAug 19, 2026
Origin Sciences Ltd. invests in three new clinic rooms in the United Kingdom in 2025 to support the colorectal urgent suspected cancer pathway.
- is_developingAug 11, 2026
Origin Sciences Ltd., working alongside SaTH, is developing a new test to detect colorectal cancer and high-risk polyps as part of the £2 million TRIOMIC cancer trial, the first study of its kind in the UK.
For institutional investors. Book with your work email.
Origin Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Origin Sciences's valuation, stock price, and market status.
Is Origin Sciences a public or private company?
Origin Sciences is a private company.
What is the current stock price of Origin Sciences?
Origin Sciences is a private company, so its shares have no public market price. Caplight tracks Origin Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Origin Sciences worth (valuation)?
Valuation information for Origin Sciences is not publicly available.
Can I buy Origin Sciences stock?
Origin Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Origin Sciences's last funding round?
Origin Sciences's most recent funding round was VC Round on October 21, 2014.
Who are the main investors in Origin Sciences?
Key investors in Origin Sciences include CSVE Ventures.
Will Origin Sciences IPO soon?
No public IPO plans have been announced for Origin Sciences.
How can I track Origin Sciences secondary market activity?
Caplight tracks bids, offers, and trades in Origin Sciences's shares on secondary markets.